Target 4

🌏 𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗞𝗠-𝗚𝗕𝗙 𝗧𝗮𝗿𝗴𝗲𝘁𝘀 🌏
🎯𝐓𝐚𝐫𝐠𝐞𝐭 𝟏𝟕: 𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧 𝐁𝐢𝐨𝐬𝐚𝐟𝐞𝐭𝐲 𝐚𝐧𝐝 𝐃𝐢𝐬𝐭𝐫𝐢𝐛𝐮𝐭𝐞 𝐭𝐡𝐞 𝐁𝐞𝐧𝐞𝐟𝐢𝐭𝐬 𝐨𝐟 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲

🤔 What do you mean by?
This Target has two main components. The first relates to biosafety measures and the second addresses participation in biotechnology research and the distribution of benefits from biotechnology.

🌿 𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐢𝐧𝐠 𝐨𝐟 𝐛𝐢𝐨𝐬𝐚𝐟𝐞𝐭𝐲 𝐦𝐞𝐚𝐬𝐮𝐫𝐞𝐬 𝐚𝐧𝐝 𝐜𝐚𝐩𝐚𝐜𝐢𝐭𝐢𝐞𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞𝐢𝐫 𝐢𝐦𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 – Biosafety measures are taken to regulate, manage and control the risks associated with the use and release of living modified organisms deriving from biotechnology. These measures aim to contribute to the sustainable use and conservation of biological diversity.

🌿𝐄𝐪𝐮𝐢𝐭𝐚𝐛𝐥𝐞 𝐚𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐫𝐞𝐬𝐮𝐥𝐭𝐬 𝐚𝐧𝐝 𝐛𝐞𝐧𝐞𝐟𝐢𝐭𝐬 – Biotechnology can generate a range of potential benefits. This component of the target promotes the participation of Parties, in particular developing countries, in biotechnological research using genetic resources provided by these Parties.   This component of the target also promotes that Parties, in particular developing countries, are provided with equitable access to the results and benefits arising from biotechnologies based on genetic resources provided by those Parties.

🌿 𝐀𝐫𝐭𝐢𝐜𝐥𝐞 𝟖(𝐠) 𝐨𝐟 𝐭𝐡𝐞 𝐂𝐨𝐧𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐨𝐧 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐃𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲 – Establish or maintain means to regulate, manage or control the risks associated with the use and release of living modified organisms resulting from biotechnology which are likely to have adverse environmental impacts that could affect the conservation and sustainable use of biological diversity, taking also into account the risks to human health.

🌿 𝐀𝐫𝐭𝐢𝐜𝐥𝐞 𝟏𝟗 𝐨𝐟 𝐭𝐡𝐞 𝐂𝐨𝐧𝐯𝐞𝐧𝐭𝐢𝐨𝐧 𝐨𝐧 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐃𝐢𝐯𝐞𝐫𝐬𝐢𝐭𝐲: Handling of Biotechnology and Distribution of its Benefits

➡️ To learn more about all 23 Targets, please visit: https://www.cbd.int/gbf/targets